Assenagon Asset Management
MRSN

Assenagon Asset Management’s Mersana Therapeutics MRSN Stock Holding History

Assenagon Asset Management’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-42,950
Closed -$6.68M – 1511
2021
Q4 		$6.68M Buy
42,950
+6,795
+19% +$1.32M 0.02% 439
2021
Q3 		$8.52M Sell
36,155
-5,483
-13% -$1.6M 0.04% 312
2021
Q2 		$14.1M Buy
+41,638
New +$15.8M 0.06% 285
2020
Q1 		– Sell
-1,371
Closed -$196K – 928
2019
Q4 		$196K Buy
+1,371
New +$100K ﹤0.01% 730
2019
Q3 		– Sell
-5,224
Closed -$529K – 988
2019
Q2 		$529K Buy
+5,224
New +$615K 0.01% 843

Other funds holding MRSN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return